LINFOMAS Y TRASPLANTES
![Foto de LINFOMAS Y TRASPLANTES](/img/grupo.png)
![Foto de Rush University Medical Center](/img/noimage_org.png)
Rush University Medical Center
Chicago, Estados UnidosPublicaciones en colaboración con investigadores/as de Rush University Medical Center (2)
2022
-
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL
Leukemia and Lymphoma, Vol. 63, Núm. 9, pp. 2063-2073
2007
-
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma
Leukemia and Lymphoma, Vol. 48, Núm. 1, pp. 39-45